![Patricia Carlos](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Patricia Carlos worked at Jasper Therapeutics, Inc. as Senior Vice President-Regulatory Affairs & Quality.
From 2019 to 2022, Ms. Carlos was Senior Vice President-Regulatory & Quality at Arcus Biosciences, Inc. From 2022 to 2023, Ms. Carlos was Chief Regulatory, Quality & Safety Officer at Agenus, Inc. Ms. Carlos completed undergraduate education at Memorial University of Newfoundland.
Antiguos cargos conocidos de Patricia Carlos.
| Empresas | Cargo | Fin |
|---|---|---|
| AGENUS INC. | Consejero General | 01/05/2023 |
| ARCUS BIOSCIENCES, INC. | Consejero General | 01/09/2022 |
| JASPER THERAPEUTICS, INC. | Consejero General | - |
Formación de Patricia Carlos.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
3
Relaciones de 1er grado
4
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Agenus, Inc.
 Agenus, Inc. BiotechnologyHealth Technology Engages in the development and commercialization of technologies to treat cancers and infectious diseases | Health Technology |
Memorial University of Newfoundland
 Memorial University of Newfoundland Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Arcus Biosciences, Inc.
 Arcus Biosciences, Inc. BiotechnologyHealth Technology Develops and commercializes novel therapies for the treatment of lung & gastrointestinal cancers | Health Technology |
Jasper Therapeutics, Inc.
 Jasper Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company which engages in enabling cures through hematopoietic stem cell therapy | Health Technology |
- Bolsa de valores
- Insiders
- Patricia Carlos
Elige MarketScreener 
